Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation-Reference-Cited by-同舟云学术

Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Published:2015-01 Issue:1 Volume:148 Page:108-117
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Charlton Michael,Gane Edward,Manns Michael P.,Brown Robert S.,Curry Michael P.,Kwo Paul Y.,Fontana Robert J.,Gilroy Richard,Teperman Lewis,Muir Andrew J.,McHutchison John G.,Symonds William T.,Brainard Diana,Kirby Brian,Dvory-Sobol Hadas,Denning Jill,Arterburn Sarah,Samuel Didier,Forns Xavier,Terrault Norah A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Hepatitis C virus kinetics during and immediately after liver transplantation;García-Retortillo;Hepatology,2002

2. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes;Prieto;Hepatology,1999

3. Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation;Berenguer;Am J Transplant,2008

4. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C;Bizollon;Am J Transplant,2005

5. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study;Samuel;Gastroenterology,2003

Cited by 314 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis;Digestive Diseases and Sciences;2024-04-05

2. Biomarkers of Innate Immunity and Immunological Susceptibility to Viral Infection in Patients with Alcoholic Cirrhosis;Biomedicines;2024-02-01

3. Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment;Life;2023-09-26

4. Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients;Viruses;2023-08-07

5. Evolving challenges with long‐term care of liver transplant recipients;Clinical Transplantation;2023-08-07